Resumo

AMADO NINO, Pilar Maritza; RUBIO ELORZA, Liliana María; VANEGAS RUIZ, Juan José  e  CORNEJO OCHOA, William. Micophenolate mofetil (MMF) in the idiopathic nephrotic syndrome (SNI) resistantance to different treatments. Iatreia [online]. 2006, vol.19, n.3, pp.236-243. ISSN 0121-0793.

THE ATTEMPT TO DIMINISH THE ADVERSE effects of the prolonged use and the great doses of steroids in the treatment of the idiopathic nephritic syndrome (SNI) with dependency and/or resistance to steroids, justifies the use of immunosuppressive drug, many of these with variable answers and also adverse effects. The objective of this work was to evaluate the clinical evolution and of the laboratory parameters in the patients with SNI to the 6 months of treatment with Mycophenolate mofetil. The trial included 11 patients with SNI, 7 with resistance and 4 with dependency to steroids, the histopathology diagnosis were: 8 focal and segmental glomeruloesclerosis (GEFS), 2 membranous glomerulonephritis (GNM), 1 membranoproliferative type II glomerulonephritis (GNMP). The average of age of beginning of the idiopathic nephritic syndrome was 7.8 years (range 2-14), and of the age at the beginning of the MMF range was 9.9 years (2.5-16). Dose average of MMF was: 406 mg/m2/12h (186.5-600). This study shows partial answer to the MMF in 4 patients and completed in 1, also we observed tendency better control of the arterial hypertension, resolution of edemas and maintenance of the stable renal function in all patients.

Palavras-chave : GLOMERULOESCLEROSIS; MICOPHENOLATE; NEPHROTIC SYNDROME.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )